Lenticular calcium, magnesium, and iron levels in diabetic rats and verapamil effect

Ophthalmic Research

Volumn 30, Issue 2, 1998, Pages 107-112

  Cekic, Osman ^a,c   Bardak, Yavuz ^b  

^a SSK Ankara Eye Hospital   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Calcium; Cataract; Diabetes; Iron; Magnesium; Verapamil

Indexed keywords

CALCIUM; CALCIUM ANTAGONIST; IRON; MAGNESIUM; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; IRON; LENS, CRYSTALLINE; MAGNESIUM; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ATOMIC; VERAPAMIL;

EID: 0031891785     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055462     Document Type: Article

References (26)

1. Bron AJ, Sparrow J, Brown NAP, Harding JJ, Blakytny R: The lens in diabetes. Eye 1993;7:260-275.
2. Aiello LM, Rand LI, Sebestyen JG, Weiss JN, Bradbury MJ, Wafai MZ, Briones JC: The eyes and diabetes; in Marble A, Krall LP, Bradley RF, Christlieb AR, Soeldner JS (eds): Jaslin's Diabetes mellitus. Philadelphia, Lea & Febiger, 1985, pp 600-634.
3. Kinoshita JH: Mechanisms initiating cataract formation. Invest Ophthalmol 1974;13:713-724.
4. Ahmad SS, Tsou KC, Ahmad SI, Rahman MA, Kirmani TH: Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. I. Cation transport and sodium potassium-dependent ATPase. Ophthalmic Res 1985;17:1-11.
5. Pierce GN, Afzal N, Kroeger EA, Lockwood MK, Kutryk MJB, Eckhert CD, Dhalla NS: Cataract formation is prevented by administration of verapamil to diabetic rats. Endocrinology 1989;125:730-735.
6. Afzal N, Ganguly PK, Dhalla KS, Pierce GN, Singal PK, Dhalla NS: Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 1988;37:936-941.
7. Chaylack LT: Classification of human cataracts. Arch Ophthalmol 1978;96:838-892.
8. Kickbright GF: Atomic Absorption Spectroscopy: Elemental Analysis of Biological Materials. Technical Report Series No 197. Vienna, International Atomic Energy Agency, 1980, pp 141-163.
9. Kador PF, Zigler JS, Konoshita JH: Alterations of lens protein synthesis in galactosemic rats. Invest Ophthalmol Vis Sci 1979;18:696-674.
10. Kilic F, Handelman GJ, Serbinova E, Packer L, Trevithick JR: Modelling cortical cataractogenesis. 17. In vitro effect of a-lipoic acid on glucose-induced lens membrane damage, a model of diabetic cataractogenesis. Biochem Mol Biol Int 1995; 37:361-370.
11. Tumminia SJ, Qin C, Zigler JS Jr, Russel P: The integrity of mammalian lenses in organ culture. Exp Eye Res 1994;5S:367-374.
12. Mitton KP, Dean PW, Dzialoszynski T, Xiong H, Sanford SE, Trevithick JR: Modelling cortical cataractogenesis. 13. Early effects on lens ATP/ADP and glutathione in the streptozotocin rat model of diabetic cataract. Exp Eye Res 1993;56:187-198.
13. Duncan G, Williams MR, Riach RA: Calcium, cell signalling and cataract. Prog Retin Eye Res 1994;13: 623-652.
14. Hightower KR, Riley MV, Mc Cready J: Regional distribution of calcium in alloxan diabetic rabbit lenses. Curr Eye Res 1989;8:517-522.
15. Clark JI, Mengel L, Bagg A, Benedek GB: Cortical opacity, calcium concentration and fiber membrane structure in the calf lens. Exp Eye Res 1980;31:399-410.
16. Hightower KR, Dering M: Development and reversal of calcium-induced opacities in vitro. Invest Ophthalmol Vis Sci 1984;25:1108-1111.
17. Fleckenstein A: Calcium antagonism: History and prospects for a multifaceted pharmacodynamic principle; in Opie LH (ed): Calcium Antagonists and Cardiovascular Disease. New York, Raven Press, 1984, pp 9-28.
18. Wallach S, Bellavia JV, Reizenstein DL, Gamponia PJ: Tissue distribution and transport of electrolytes Mg and Ca in hypermagnesemia. Metabolism 1967;16:451-464.
19. Baldwin GF, Bentley PJ: Some observations on the magnesium metabolism of the amphibian lens. Exp Eye Res 1980;31:665-671.
20. Burge WE: Analyses of the ash of the normal and cataractous lens. Arch Ophthalmol 1909;38:435-450.
21. Ringvold A, Sagen E, Bjerve KS, Folling I: The calcium and magnesium content of the human lens and aqueous humour. A study in patients with hypocalcemic and senile cataract. Acta Ophthalmol 1988;66: 153-156.
22. Duhaiman AS, Rabbani N, Cotlier E: Camel lens crystallin glycosylation and high molecular weight aggregate formation in the presence of ferrous ions and glucose Biochem Biophys Res Commun 1990;173: 823-832.
23. Yugay MT, Pereira PC, Leiria F, Mota MC: Oxidative damage to lens membranes induced by metal-catalyzed systems. Ophthalmic Res 1996;28(suppl):92-96.
24. Garland D, Zigler JS, Kinoshita J: Structural changes in bovine lens crystallins induced by ascorbate, metal, and oxygen. Arch Biochem Biophys 1986;251:771-776.
25. Crabbe MJC: Aldose reductase inhibitors and cataract. Int Ophthalmol 1991;15:25-36.
26. WoIff SP: Diabetes mellitus and free radicals: Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993; 49:642-652.